文献速递瓣膜外科主动脉外科

重度主动脉瓣狭窄合并胸腹主动脉瘤:TAVI与T/EVAR同期 versus 分期治疗对比

Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

同期组住院时间更短、肺部事件和术后起搏器需求更少,30天死亡率和3年生存率无差异。两种策略均有效,同期手术可能减少住院时间和肺部并发症。

要点

  • 同期TAVI+T/EVAR较分期手术住院时间更短(7天 vs 19天,P=0.001)。
  • 分期组肺部事件和术后起搏器需求更高(P=0.01和P=0.02)。
  • 两组30天死亡率和3年生存率无显著差异。

核心结论

  • 同期或分期T/EVAR与TAVI均有效且结局满意。
  • 同期修复可能缩短住院时间并减少肺部并发症,随访生存率相似。

研究设计与样本

  • 同期组25例(57%)在同一手术中完成,分期组19例(43%)在3个月内分两步完成。

主要发现

  • 分期组两次手术中位间隔72天(IQR 57-87)。
  • 30天死亡率:同期组0/25 vs 分期组1/19(P=0.43)。
  • 肺部事件:同期组0/25 vs 分期组5/19(P=0.01)。
  • 术后需心脏起搏器:同期组2/25 vs 分期组7/19(P=0.02)。
  • 总住院时间:同期组7天(IQR 6-8) vs 分期组19天(IQR 15-23)(P=0.001)。

临床怎么用

  • 对于同时存在重度主动脉瓣狭窄和胸腹主动脉瘤的高危患者,可考虑同期行TAVI和T/EVAR以缩短住院时间并减少肺部并发症。
  • 分期手术仍为有效选择,但需注意肺部事件和起搏器需求可能更高。

局限性

  • 回顾性观察性设计存在选择偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Thoracic/abdominal aortic aneurysms and aortic stenosis may be concomitant diseases requiring both transcatheter aortic valve implantation (TAVI) and endovascular aneurysm repair (T/EVAR) in high-risk patients for surgical approaches, but temporal management is not clearly defined yet. The aim of the study was to analyse outcomes of simultaneous versus staged TAVI and T/EVAR. METHODS: Retrospective observational multicentre study was performed on patients requiring TAVI and T/EVAR from 2016 to 2022. Patients were divided into 2 groups: 'Simultaneous group' if T/EVAR + TAVI were performed in the same procedure and 'Staged group' if T/EVAR and TAVI were performed in 2 steps, but within 3 months. Primary outcomes were technical success, 30-day mortality/major adverse events and follow-up survival. Secondary outcomes were procedural metrics and length of stay. RESULTS: Forty-four cases were collected; 8 (18%) had T/EVAR and 36 (82%) had EVAR, respectively. Upon temporal determination, 25 (57%) and 19 (43%) were clustered in Simultaneous and Staged groups, respectively. In Staged group, median time between procedures was 72 (interquartile range-IQR: 57-87) days. Preoperative and intraoperative figures were similar. There was no difference in 30-day mortality (Simultaneous: 0/25 versus Staged: 1/19; P = 0.43). Pulmonary events (Simultaneous: 0/25 versus Staged: 5/19; P = 0.01) and need of postoperative cardiac pacemaker (Simultaneous: 2/25 versus Staged: 7/19; P = 0.02) were more frequent in Staged patients. The overall length of stay was lower in the Simultaneous group [Simultaneous: 7 (IQR: 6-8) versus Staged: 19 (IQR: 15-23) days; P = 0.001]. The median follow-up was 25 (IQR: 8-42) months and estimated 3-year survival was 73% with no difference between groups (Simultaneous: 82% versus Staged: 74%; P = 0.90). CONCLUSIONS: Both Simultaneous or Staged T/EVAR and TAVI procedures are effective with satisfactory outcomes. Despite the small numbers, simultaneous repair seems to reduce length of stay and pulmonary complications, maintaining similar follow-up survival.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Gallitto E, Spath P, Faggioli GL, et al. Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm. Eur J Cardiothorac Surg. 2024. PMID: 39441830. doi:10.1093/ejcts/ezae379

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。